Recent Research Funding

Faculty secure several million dollars annually for their research from various public and private sources, including the National Institutes of Health, U.S. Food and Drug Administration, National Multiple Sclerosis Society, foundations and pharmaceutical firms.

  • A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis, BEAT-MS (Protocol ITN077AI). Bianca Weinstock-Guttman (Principal Investigator). National Institute of Allergy & Infectious Diseases (NIAID), Division of Allergy, Immunology &Transplantation (DAIT) via a subaward. 1/1/2020-12/1/2026.
  • Optimizing Chest Compressions Targeting Gas Exchange and Hemodynamics in a Transitional Cardiac Arrest Model. Ferdinand Schweser (Co-Investigator). National Institutes of Health. $1,642,389. 4/1/2021-3/1/2026.
  • A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063). Bianca Weinstock-Guttman (Principal Investigator). Celgene International. 6/1/2020-12/1/2025.
  • Deep gray matter iron and disease progression in multiple sclerosis. Ferdinand Schweser (Principal Investigator). National Institutes of Health. $1,808,000. 7/1/2021-6/1/2025.
  • Feasibility of the Multiple Sclerosis Performance Test for assessment of functional performance measures in patients with Multiple Sclerosis (US-MSG-18-11424). Bianca Weinstock-Guttman (Principal Investigator). Biogen. 6/1/2019-12/1/2024.
  • Buffalo Clinical and Translational Research Center. Ferdinand Schweser (Co-Investigator). National Institutes of Health. $19,101,902. 2/1/2020-12/1/2024.
  • Buffalo Clinical and Translational Research Center. Kinga Szigeti (Co-Investigator). NIH/NCATS. 7/1/2019-7/1/2024.
  • Investigation of behavioral and neural indices of multisensory information processing in Multiple Sclerosis: A novel approach. Thomas Covey (Principal Investigator). Department of Defense Multiple Sclerosis Research Program. $232,022. 9/1/2021-9/1/2023.
  • Investigation of novel neural indices of cognitive decline and methods for cognitive rehabilitation in people with neurological disturbances. Thomas Covey (Principal Investigator). National Institutes of Health Loan Repayment Program Award. $38,343. 9/1/2021-9/1/2023.
  • Advanced hybrid PET-MRI imaging pipeline at 9.4T. Ferdinand Schweser (Principal Investigator). University at Buffalo. $100,000. 8/1/2021-7/1/2023.
  • Network of Excellence in Neuroscience Clinical Trial: NeuroNEXT. Gil Wolfe (Principal Investigator). NIH/NINDS. $250,000. 7/1/2018-6/1/2023.
  • A novel method for the investigation of the neural underpinnings of performance on the Symbol Digit Modalities Test in Multiple Sclerosis. Thomas Covey (Principal Investigator). National Multiple Sclerosis Society. $55,000. 10/1/2020-9/1/2022.
  • Supporting an aging workforce in future transportation and delivery work. Thomas Covey (Co-Principal Investigator). National Science Foundation. $149,580. 10/1/2020-9/1/2022.
  • Neonatal Research Network. Osman Farooq (Co-Investigator), Michelle Hartley-McAndrew (Co-Investigator), Anne Marie Reynolds (Co-Principal Investigator). Eunice Kennedy Shriver National Institute of Child Health and Human Development. 4/1/2011-8/1/2022.
  • A study to evaluate the natural history of secondary progressive multiple sclerosis in never-treated or late starters compared to early treated patients. Bianca Weinstock-Guttman (Principal Investigator). Novartis. 3/1/2021-8/1/2022.
  • The role of acute and chronic neuroinflammation on iron homeostasis and oligodendrocyte viability in the deep gray matter. Ferdinand Schweser (Principal Investigator). The Dana Foundation. $200,000. 9/1/2017-7/1/2022.
  • Physiological mechanisms of a biomarker of recovery from a concussion. Ferdinand Schweser (Co-Investigator). National Institutes of Health. $1,723,492. 4/1/2016-3/1/2022.
  • The effects of Post-Traumatic Stress Disorder (PTSD) symptoms on behavioral, psychological, and neurophysiological measures of decision making in police officers. Thomas Covey (Co-Principal Investigator). National Institutes of Justice. $814,158. 1/1/2018-1/1/2022.
  • Human-machine interaction and agin. Thomas Covey (Co-Principal Investigator). SUNY Research Seed Grant Program. $30,000. 1/1/2021-1/1/2022.
  • Evaluation of patient-reported outcomes associated with use of dimethyl fumarate in a real-world setting. Bianca Weinstock-Guttman (Principal Investigator). Biogen. 12/1/2019-12/1/2021.